CME and CFTC Clash Over On-Chain Perpetual Futures

The US Commodity Futures Trading Commission's recent approval of crypto perpetual futures has sparked a heated dispute with the Chicago Mercantile Exchange, the largest derivatives exchange operator in the US. The CME has filed a lawsuit against the CFTC, challenging the regulator's decision to allow the listing of these products, which enable users to speculate on asset prices with leverage and no expiration date. The CME claims that the CFTC is misapplying the law by allowing these products, which it argues are harmful to its traditional futures contracts. The regulator, however, believes that the CME is attempting to stifle competition and innovation in the market. The dispute has significant implications for the US approach to the rapidly growing market for perpetual futures, with non-US volume reportedly reaching $60 trillion last year. The CME's lawsuit argues that the CFTC's approval of these products did not consider the potential consequences and that the regulator is mislabeling them as futures when they are, in fact, swaps. The CFTC, on the other hand, believes that the CME is trying to maintain its dominance in the market and prevent the emergence of new competitors. The dispute has sparked a wider debate about the regulation of perpetual futures and the role of the CFTC in overseeing the market. Some experts argue that the CFTC's approach is too permissive and that the regulator needs to take a more nuanced approach to regulating these products. Others believe that the CME is trying to use its influence to stifle innovation and competition in the market. The outcome of the dispute is uncertain, but it is likely to have significant implications for the future of the perpetual futures market in the US.